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INTRODUCTION 
The sex-linked mutation, myelin synthesis deficiency of  the mouse (gene symbol, 
msd), causes a severe defect in brain myelination6, 7. Myelin components, particularly 
galactosyl ceramide*, are greatly reduced in concentration or absent. Since the primary 
genetic defect might be an inability to make galactocerebroside, by galactosylation of 
ceramide s,9, we assayed mutant and normal brains for the enzyme which carries out 
this step. For  comparison, we assayed the brains as well for the glucosyltransferase 
which makes glucocerebroside and for the galactosidase which hydrolyzes galacto- 
cerebroside. Glucocerebroside appears to be an intermediate in ganglioside metab- 
olism1,15, which is normal in the mutant 7. The hydrolase was of interest because the 
lack of galactocerebroside could be due to overactivity of  the hydrolase rather than 
insufficient synthesis. 
The activities of  the 3 enzymes follow quite different patterns of  change with 
age in rats 3,4, and it seemed important  to compare these changes in normal and mutant 
mice. Such an approach might allow one to distinguish between primary and secon- 
dary abnormalities. 
MATERIALS AND METHODS 
Tissues 
The mice were bred, sacrificed, and dissected at The Jackson Laboratory, and 
the brains were shipped in dry ice and stored at --75°C. The brains were stored at 
---60°C for 67-423 days before shipment. 
* Nomenclature: Galactosyl ceramide is galactocerebroside; glucosyl ceramide is glucocerebroside. 
Both lipids are commonly called cerebroside. 
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Assay procedures 
The procedures for the transferases are described by Brenkert and Radin ~. 
Higher levels of tissue (2 mg dry weight) were used here. The assays were carried out 
the next day after lyophilizing the tissue. 
For the assay of  cerebroside galactosidase, 2 mg of lyophilized brain was 
used rather than the purified enzyme a. This results in dilution of the radioactive 
cerebroside by endogenous cerebroside, an effect which increases with age as cerebro- 
side accumulation occurs. Since, in the oldest animals, the amount of  endogenous 
substrate was only about one-fourth the weight of  radioactive substrate, the resultant 
error should not be serious. An improved substrate preparation and work-up pro- 
cedure were used 12. 
R E S U L T S  
Galactocerebroside biosynthesis 
Normal and affected mice exhibit two widely differing activities at all ages 
studied (Fig. 1). The normal mice show changes with age that greatly resemble those of 
rats, with transferase activity rising rapidly to about 17 days, and decreasing rapidly 
thereafter 4. The mutant mice, which are usually but not always identifiable by 
clinical abnormalities at 8 or 9 days, show a much smaller rise in activity. The 
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Fig. 1. Changes with age in hexosyltransferase activity. O = galactosyltransferase in normal mice. 
• -- galactosyltransferase in msd/Y mice. & = glucosyltransferase in both groups. Assay medium 
for galactosyltransferase: 0.2 ml containing 0.1 M Tris pH 7.4, 15 mM MnCh, 2 mM EDTA, 1 mM 
dithiothreitol, 5 mM nicotinamide, 0.16 mM 14C-UDPgalactose, 2 mg dry brain, 0.2 mg hydroxy 
ceramide; incubated 2 h at 37'~C. Assay for glucosyltransferase is similar, but 14C-UDPGIc is the 
labeled compound, nonhydroxy ceramide is used, and 2 mM ATP is included. 
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activities in the youngest mutants are 5 0 ~  of  normal and, in the 17-day mutants, 
15 ~ of  normal.  
While only a single msd brain was available at the 8-day time point, previous 
assays of  the galactosyltransferase using a different assay procedure yielded a similar 
difference between three 9-day-old msd mice and 3 littermates. 
Glucocerebroside biosynthesis 
There appears to be no difference in glucosyltransferase activities between the 
two genotypes (Table I). Both show a rather steady decrease in activity with age 
(Fig. 1). A less continuous decrease had been noted in rats but the overall pattern is 
comparable a. The ratio of  galactosyl- and glucosyltransferase activities at each age is 
quite similar in both rats and mice, i.e., low at 8 days and high after 16 days. 
Galactocerebroside galactosidase 
There is little difference between normal  and affected mice at all ages (Table I). 
The lower activities seen in older normal mice are presumably the result of  the use 
of  whole brain, rather than purified enzyme, since there is only negligible dilution 
of the radioactive substrate in the msd samples. 
Test for  the presence o f  an inhibitor 
We thought that a possible explanation |b r  the low galactosyltransferase activity 
in the mutants might be the presence in mutants of  an inhibitor in high concentration. 
TABLE II 
SYNTHESIS OF GALACTOSYL CERAMIDE BY MIXTURES OF BRAIN POWDERS FROM NORMAL AND MUTANT MICE 
The assay procedure is described in Fig. 1. 
Powder used Cerebroside formed 
(nmoles) 
17-day msd/ Y 17-day normal 8-day normal 












* These incubations were run without added hydroxy ceramide acceptor. 
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This possibility was tested by mixing normal and affected mouse brain and comparing 
the activity with similar amounts of separate brain powders (Table II). The comparison 
is complicated by the lack of linearity with respect to tissue weight: doubling the 
weight of normal brain yields only 47 % more activity in 17-day mice, and 89 % more 
at 8 days. In mutant mice 17 days old, the increase is only 29%. 
The mixture of 1 mg each of 17-day normal and mutant mouse brain gives an 
activity (2.45 nmoles) that is only 72 % of the activity expected from the sum of the 
1 mg activities (2.87 -+- 0.51 = 3.38 nmoles). This would indicate the presence of some 
inhibitory compound, although its effect does not seem large enough to account for 
the difference between the two groups. If the activity of the mixture is compared 
with the average of the two activities at the 2 mg level ((4.21 4- 0.66)/2 -- 2.44), there 
is no evidence of an inhibitor. However, the poor linearity in all preparations suggests 
that there exists normally some inhibitor in all brains. 
A similar comparison between normal 8-day and 17-day mice (middle of Table 
II) shows that the mixture has 78 % of the expected activity, again indicating the 
presence of a natural inhibitor. It seems unlikely that the low activity seen in young 
mice is due to a high concentration of the inhibitor. 
The activities observed without addition of exogenous acceptor substrate 
(bottom of Table II) reflect utilization of endogenous nonhydroxy ceramide 4. 
Characterization of the galactosyltransferase in normal and mutant mice 
In the case of Krabbe disease, a disorder caused by a deficiency of galacto- 
cerebroside galactosidase 14, the residual hydrolase activity in the affected individuals 
has an abnormal pH/activity curve, and the possibility exists therefore that the residual 
activity is due to a different enzyme. A similar explanation could be given for our 
finding that the mutant mice do not entirely lack the galactocerebroside synthesizing 
enzyme. To test this, we measured the Km of the transferase in 17-day-old mice of 
both genotypes with respect to binding of UDPGal. We found that the Kra (5.7 • 10 -5) 
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Fig. 2. Lineweaver-Burk plot relating galactocerebroside synthesis (nmoles) to UDPGal concen- 
tration (mM). Conditions are the same as in Fig. 1 except that incubation is for 90 min using 1 mg 
brain powder. Lower curve obtained with normal mice. 
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was quite similar for both the msd/Y and its normal littermate. A similar observation 
was made by Neskovic et al. lo with Jimpy and Quaking mice in an assay of the 
galactosyltransferase which forms psychosine. It is not yet known whether this is the 
same enzyme that forms galactocerebroside. 
DISCUSSION 
In an ongoing study 4 we have obtained evidence that glial and neuronal cell 
preparations, given the labeled substrates, can hydrolyze and synthesize galacto- 
cerebroside. The synthetic activity in neurons is somewhat lower than in glia, but 
still appreciable. These findings are supported by the report of  Norton and Turn- 
bull 11 and of  Raghavan and Kanfer 13, who found galactocerebroside in isolated 
axonal and neuronal preparations. 
An assay of whole brain must therefore reflect the synthetic capacity of neurons 
as well as glia. Our present findings (Fig. 1) can thus be explained to mean that the 
mutant mice (msd/Y) contain little galactocerebroside synthesizing ability in their 
non-neuronal cells, but normal activity in their neurons. At 8 days of age it appears 
from this hypothesis that as much as 50 ~ of the normal observed transferase activity 
derives from neurons; at 17 days, the neuronal activity is increased moderately but 
the glial activity is increased considerably, so as to give a ratio of about 7 : 1. 
This interpretation also explains the presence of some galactosyltransferase 
activity (toward sphingosine) in Jimpy and Quaking micO 0. It is consistent with our 
observation (Table II) that the synthesis of galactocerebroside from endogenous 
ceramide is the same in both mutant and normal mice. Apparently the synthesis 
seen in the absence of  added ceramide is due primarily to the enzyme in neurons, 
rather than in glia. Costantino-Ceccarini and Morell 5 have recently obtained data 
rather similar to ours with Quaking mice, finding low galactosyl ceramide synthesizing 
ability in the mutants at every age. It is thus possible that Quaking mice, like msd/Y 
mice, contain galactosyltransferase primarily in their neurons. 
As part of our study, we examined a litter of two Jimpy mice (Ta jp/Y) and 
compared them with their two normal littermates ( ÷  +/Y) ,  17 days old. The normal 
brains exhibited activities of 5.06 nmoles galactocerebroside formed in 2 h, and the 
mutants exhibited 0.77 nmoles formation. These activities were very close to those 
found with msd/Y mice (Table I) and were included in Fig. 1. The possibility exists 
that msd is an allele o f jp  7. There was also noted a strong resemblance between the 
two mutants in the other two enzymes studied: glucosyltransferase activity was 2.76 
nmoles in the normals and 2.41 in thejp mice; galactosidase activity was 6.99 nmoles 
in the normals and 8.40 nmoles in thejp mice (compare Table I). It is thus likely that 
Jimpy mice, like msd and Quaking mice, contain a normal concentration of  galacto- 
cerebroside synthesizing enzyme in their neurons but little in their glia. 
Our use of brains which had been stored a long time, for various periods, in- 
troduces some question about the assay validity. However, our age curves match 
those seen with freshly removed rat brains 4 and are fairly similar to those obtained 
with Quaking mice and their littermates 5. The differences between normal and mutant 
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mice were observed also in mouse brains which were shipped promptly after removal. 
The question of which is the primary genetic defect in mice with the mutation, 
msd, as in the other neurological syndromes exhibiting abnormal myelination, remains 
open. It does not appear likely that myelin-forming cells are markedly absent, since 
the galactocerebrosidase concentration is approximately normal. There is a small 
decrease in cerebroside galactosidase activity in Quaking mice, but not in Jimpy 
mice 2. In the latter mice, the enzyme appears to be somewhat more readily solubilized 
or dispersed but this may be a secondary phenomenon. 
SUMMARY 
Three enzymes related to myelin and ganglioside metabolism in the brains of  
normal and mutant (msd/Y) mice were compared through the ages 8-21 days old. 
No difference is seen in the glucosyltransferase which makes glucocerebroside or in 
the galactosidase which hydrotyzes galactocerebroside. However, the galactosyl- 
transferase which makes galactocerebroside is markedly decreased in the mutants. 
The difference is most pronounced at 17 days, which is the age of  maximal normal 
activity (15 ~ of  normal); it is 50 ~ of  normal in 8-day mice. 
This variation with age is interpreted to mean that the galactosyltransferase in 
neurons is normal in both genotypes, but somewhat defective in the glia of  msd/Y 
mice. 
The affinity of  the enzyme for its nucleotide substrate, UDPGal,  is the same in 
normal and affected animals. Mixing experiments indicate that the difference in 
enzyme activities is not due primarily to the presence of  an endogenous inhibitor. 
A comparison of  Jimpy mice and normal littermates 17 days old reveals 
enzymatic relationships similar to those seen in 17-day msd and normal mice. 
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